Non-benzodiazepine sedative-hypnotic (Z-drug)

Lunesta (eszopiclone) Withdrawal

Lunesta (eszopiclone) has a slightly longer half-life than Ambien and a somewhat smoother discontinuation profile, but the same fundamental rebound-insomnia pattern applies. Chronic use produces dependence and stopping reliably produces rebound effects.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~6 hours.

Withdrawal timeline

Onset— 12-24 hours after stopping

Rebound emerges within a day.

Peak— Days 2-5

Rebound insomnia peaks in the first 5 days.

Resolution— 1-3 weeks

Acute rebound resolves over 1-3 weeks.

Common symptoms

  • Rebound insomnia
  • Anxiety
  • Vivid dreams
  • Irritability

Less common

  • Sweating
  • Headache

Tapering guidance

  • Halve the dose for 1-2 weeks, then stop.
  • Plan sleep-support strategies before tapering.

Where ketamine therapy fits

Same considerations as Ambien. Lunesta acts on GABA and can blunt ketamine's effect. Avoid on session days; coordinate with the prescribing physician.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

How long does Lunesta withdrawal last?

Acute rebound insomnia typically peaks in the first 5 days and resolves over 1-3 weeks.

Is Lunesta compatible with ketamine therapy?

Avoid on session days because Lunesta blunts ketamine's effect. Plan sessions for times when the prior dose has cleared.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.